CD274 and head and neck squamous cell carcinoma: In HNSCC cell lines, activation of epidermal growth factor receptor (EGFR), an established oncogenic driver and therapeutic target in HNSCC, was shown to positively regulate PDL1 expression on the cell surface [8].